Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008

Hepatology

Volumn 51, Issue 2, 2010, Pages 431-434

  Rein, David B ^a   Lesesne, Sarah B ^a   O'Fallon, Ann ^b   Weinbaum, Cindy M ^c  

^a RTI INTERNATIONAL   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

AFRICA; ARTICLE; ASIA; CONTROLLED STUDY; EUROPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; REFUGEE; SCREENING TEST; UNITED STATES;

HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; PREVALENCE; REFUGEES; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; UNITED STATES;

EID: 75449093196     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23353     Document Type: Article

References (13)

1. World Health Organization. Immunization, vaccines and biologicals, hepatitis B. Available at: http://www.who.int/immunization/topics/hepatitis-b/ en/index.html. Accessed November 11, 2008.
2. Di Marco V, Craxi A. Chronic hepatitis B: who to treat and which choice of treatment? Expert Rev Anti Infect Ther 2009;7:281-291.
3. Expanded Programme on Immunization of the Department of Vaccines and Biologicals. Introduction of hepatitis B vaccine into childhood immunization services management guidelines, including information for health workers and parents. Geneva, Switzerland: World Health Organization; 2001.
4. Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep 2008;57:1-20.
5. Centers for Disease Control (CDC). Screening for hepatitis B virus infection among refugees arriving in the United States, 1979-1991. MMWR Morb Mortal Wkly Rep 1991;40:784-786.
6. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209-212.
7. World Health Organization. Myanmar, in review of the current situation of hepatitis B and the progress in the introduction of hepatitis B vaccine in the South-East Asia Region. Geneva, Switzerland: World Health Organization; 2007.
8. Janani MR, Motevalian SA, Mahmoodi M. Hepatitis B carriers in large vehicle drivers of Iran. Vaccine 2003;21:1948-1951.
9. Galban EBJ, Casatañeda C, Toledo G, González A, Delgado MG. Ensayo de campo de la vacuna recombinante cubana contra hepatitis B (Heberbiovac HB). Estudio en recién nacidos hijos de madres HBsAg positivas. Revista Cubana Medical Tropical 1992;44:149-157.
10. Welch S, Chiang B, Shadday P, Brosgart CL. Estimated prevalence of chronic hepatitis B in foreign-born persons living in the United States by country/ region of origin. Presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases. San Francisco, CA; 2008.
11. Hanssen-Bauer J, Jacobsen LB. Living in provisional normality: the living conditions of Palestinian refugees in the host countries of the Middle East. In: Brynen R, El-Rifai R, eds. Palestinian refugees: challenges of repatriation and development. New York: I. B. Tauris, International Development Research Centre; 2007:29-45.
12. Akbar N, Basuki B, Mulyanto, Garabrant DH, Sulaiman A, Noer HM. Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol 1997;12:752-757.
13. US Census Bureau. International Data Base: world population by age and sex. Available at: http://www.census.gov/ipc/www/idb/index.php. Accessed September 22, 2009.